Start for free
Start for free
KC

Kingsbridge Capital

Europe, England, United Kingdom, London

Description

Kingsbridge Capital is an investment company based in London, United Kingdom.

Investor Profile

Kingsbridge Capital has made 5 investments, with 0 in the past 12 months and 20% as lead.

Stage Focus

  • Series Unknown (60%)
  • Post Ipo Equity (40%)

Country Focus

  • United States (80%)
  • Germany (20%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Biopharma
  • Medical
  • Children
  • Manufacturing
  • Textiles
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kingsbridge Capital frequently co-invest with?

DC
Downsview Capital
North America, Illinois, United States, Deerfield
Co-Investments: 1
Iroquois Capital
Iroquois Capital
North America, Tennessee, United States, Nashville
Co-Investments: 1
OP
OpusPoint Partners
North America, New York, United States, New York
Co-Investments: 1
Rosalind Capital Partners
Rosalind Capital Partners
North America, Ontario, Canada, Toronto
Co-Investments: 1
Dafna Capital Management
Dafna Capital Management
North America, California, United States, Los Angeles
Co-Investments: 1
RC
Rockmore Capital
North America, New York, United States, New York
Co-Investments: 1
BC
Brio Capital Management
North America, New York, United States, New York
Co-Investments: 1
Leadiant Biosciences
Leadiant Biosciences
North America, Maryland, United States, Gaithersburg
Co-Investments: 1

What are some of recent deals done by Kingsbridge Capital?

Soligenix

Princeton, New Jersey, United States

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

BiopharmaBiotechnologyHealth CareMedical
Series UnknownJul 2, 2010
Amount Raised: $5,904,277
Jazz Pharmaceuticals

Palo Alto, California, United States

Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquityMay 8, 2008
Amount Raised: $75,000,000
Kosan Biosciences

Hayward, California, United States

Kosan Biosciences is a cancer therapeutics company developing various classes of anticancer agents through clinical development.

BiotechnologyTherapeutics
Series UnknownJul 19, 2006
Amount Raised: $3,000,000
Tercica

Brisbane, California, United States

Tercica, a biotechnology company, develops and commercializes therapeutics for the treatment of endocrine and metabolic diseases.

BiotechnologyChildrenPharmaceutical
Post Ipo EquityOct 14, 2005
Amount Raised: $75,000,000
KUNERT Fashion GmbH

Isny Im Allgäu, Baden-Wurttemberg, Germany

KUNERT Fashion GmbH manufactures and markets stockings and socks for women.

ManufacturingTextiles
Series UnknownJan 1, 2005
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator